NVS logo

Novartis AG (NVS) Selling, general & administrative expenses

annual SGA:

$0.00-$12.52B(-100.00%)
December 31, 2024

Summary

  • As of today (August 19, 2025), NVS annual SGA is $0.00, with the most recent change of -$12.52 billion (-100.00%) on December 31, 2024.
  • During the last 3 years, NVS annual SGA has fallen by -$14.89 billion (-100.00%).
  • NVS annual SGA is now -100.00% below its all-time high of $17.86 billion, reached on December 31, 2011.

Performance

NVS SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

quarterly SGA:

$3.50B+$439.27M(+14.36%)
June 30, 2025

Summary

  • As of today (August 19, 2025), NVS quarterly SGA is $3.50 billion, with the most recent change of +$439.27 million (+14.36%) on June 30, 2025.
  • Over the past year, NVS quarterly SGA has increased by +$406.27 million (+13.14%).
  • NVS quarterly SGA is now -31.15% below its all-time high of $5.08 billion, reached on December 31, 2010.

Performance

NVS quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

TTM SGA:

$174.22B-$4.31B(-2.41%)
June 30, 2025

Summary

  • As of today (August 19, 2025), NVS TTM SGA is $174.22 billion, with the most recent change of -$4.31 billion (-2.41%) on June 30, 2025.
  • Over the past year, NVS TTM SGA has increased by +$161.75 billion (+1297.55%).
  • NVS TTM SGA is now -19.95% below its all-time high of $217.64 billion.

Performance

NVS TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

NVS Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%+13.1%+1297.5%
3 y3 years-100.0%-2.3%+1085.5%
5 y5 years-100.0%+3.8%+1117.6%

NVS Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-2.3%>+9999.0%-19.9%+174.2%
5 y5-year-100.0%at low-12.2%>+9999.0%-19.9%+204.8%
alltimeall time-100.0%at low-31.1%>+9999.0%-19.9%+630.2%

NVS Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$3.50B(+14.4%)
$9.69B(+4.4%)
Mar 2025
-
$3.06B(>+9900.0%)
$9.28B(+2.4%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$9.06B(-27.5%)
Sep 2024
-
$3.13B(+1.4%)
$12.51B(+0.3%)
Jun 2024
-
$3.09B(+8.8%)
$12.47B(0.0%)
Mar 2024
-
$2.84B(-17.5%)
$12.47B(-0.4%)
Dec 2023
$12.52B(+2.7%)
$3.44B(+11.4%)
$12.52B(+2.1%)
Sep 2023
-
$3.09B(0.0%)
$12.26B(+1.3%)
Jun 2023
-
$3.09B(+6.9%)
$12.10B(-3.9%)
Mar 2023
-
$2.89B(-9.2%)
$12.59B(-4.7%)
Dec 2022
$12.19B(-18.1%)
$3.18B(+8.4%)
$13.21B(-5.7%)
Sep 2022
-
$2.94B(-18.0%)
$14.01B(-4.6%)
Jun 2022
-
$3.58B(+2.0%)
$14.70B(-1.2%)
Mar 2022
-
$3.51B(-11.9%)
$14.87B(-0.1%)
Dec 2021
$14.89B(+4.9%)
$3.98B(+10.1%)
$14.89B(+0.4%)
Sep 2021
-
$3.62B(-3.6%)
$14.82B(+1.4%)
Jun 2021
-
$3.75B(+6.4%)
$14.63B(+2.7%)
Mar 2021
-
$3.53B(-10.1%)
$14.24B(+0.3%)
Dec 2020
$14.20B(-1.2%)
$3.92B(+14.8%)
$14.20B(+0.1%)
Sep 2020
-
$3.42B(+1.5%)
$14.18B(-0.9%)
Jun 2020
-
$3.37B(-3.4%)
$14.31B(-1.5%)
Mar 2020
-
$3.49B(-10.7%)
$14.53B(+1.1%)
Dec 2019
$14.37B(+4.8%)
$3.90B(+10.0%)
$14.37B(+1.6%)
Sep 2019
-
$3.55B(-1.0%)
$14.14B(+2.1%)
Jun 2019
-
$3.58B(+7.7%)
$13.85B(+0.7%)
Mar 2019
-
$3.33B(-9.4%)
$13.76B(+0.3%)
Dec 2018
$13.72B(-8.5%)
$3.68B(+12.8%)
$13.72B(-2.6%)
Sep 2018
-
$3.26B(-6.7%)
$14.08B(-2.9%)
Jun 2018
-
$3.50B(+6.4%)
$14.50B(-2.1%)
Mar 2018
-
$3.28B(-18.7%)
$14.81B(-1.3%)
Dec 2017
$15.00B(+5.7%)
$4.04B(+9.9%)
$15.00B(+1.4%)
Sep 2017
-
$3.68B(-3.4%)
$14.79B(+1.9%)
Jun 2017
-
$3.81B(+9.6%)
$14.52B(+1.1%)
Mar 2017
-
$3.47B(-9.5%)
$14.36B(+1.2%)
Dec 2016
$14.19B(-0.4%)
$3.84B(+12.9%)
$14.19B(-0.3%)
Sep 2016
-
$3.40B(-6.8%)
$14.24B(-0.4%)
Jun 2016
-
$3.65B(+10.4%)
$14.30B(+0.2%)
Mar 2016
-
$3.31B(-14.9%)
$14.27B(+0.2%)
Dec 2015
$14.25B(-5.0%)
$3.88B(+12.2%)
$14.25B(-0.6%)
Sep 2015
-
$3.46B(-4.3%)
$14.33B(-0.7%)
Jun 2015
-
$3.62B(+10.2%)
$14.43B(-1.9%)
Mar 2015
-
$3.28B(-17.2%)
$14.71B(-6.7%)
Dec 2014
$14.99B(-1.6%)
$3.96B(+11.2%)
$15.76B(-1.1%)
Sep 2014
-
$3.56B(-8.6%)
$15.94B(-0.7%)
Jun 2014
-
$3.90B(-10.0%)
$16.05B(+0.7%)
Mar 2014
-
$4.33B(+4.5%)
$15.93B(+0.6%)
Dec 2013
$15.24B(-11.9%)
$4.15B(+12.8%)
$15.84B(-3.0%)
Sep 2013
-
$3.67B(-2.9%)
$16.34B(-1.6%)
Jun 2013
-
$3.78B(-10.7%)
$16.60B(-2.2%)
Mar 2013
-
$4.24B(-8.6%)
$16.96B(+1.5%)
Dec 2012
$17.29B
$4.64B(+17.9%)
$16.72B(+0.1%)
Sep 2012
-
$3.93B(-5.2%)
$16.70B(-4.6%)
Jun 2012
-
$4.15B(+3.9%)
$17.51B(-4.6%)
DateAnnualQuarterlyTTM
Mar 2012
-
$3.99B(-13.5%)
$18.36B(-2.6%)
Dec 2011
$17.86B(+14.0%)
$4.62B(-2.6%)
$18.84B(-2.4%)
Sep 2011
-
$4.74B(-5.2%)
$19.30B(+5.1%)
Jun 2011
-
$5.00B(+11.8%)
$18.36B(+8.8%)
Mar 2011
-
$4.48B(-11.9%)
$16.88B(+5.6%)
Dec 2010
$15.67B(+9.8%)
$5.08B(+33.6%)
$15.99B(+4.3%)
Sep 2010
-
$3.80B(+7.9%)
$15.32B(+2.8%)
Jun 2010
-
$3.52B(-1.7%)
$14.90B(-0.1%)
Mar 2010
-
$3.58B(-18.8%)
$14.91B(+2.5%)
Dec 2009
$14.28B(+1.4%)
$4.41B(+30.6%)
$14.55B(+5.3%)
Sep 2009
-
$3.38B(-4.4%)
$13.82B(-0.7%)
Jun 2009
-
$3.53B(+9.6%)
$13.92B(-1.0%)
Mar 2009
-
$3.23B(-12.4%)
$14.06B(-0.1%)
Dec 2008
$14.08B(+6.2%)
$3.68B(+6.1%)
$14.07B(+0.0%)
Sep 2008
-
$3.47B(-5.5%)
$14.06B(+2.1%)
Jun 2008
-
$3.68B(+13.5%)
$13.77B(+2.7%)
Mar 2008
-
$3.24B(-12.0%)
$13.42B(+0.6%)
Dec 2007
$13.26B(+10.7%)
$3.68B(+15.7%)
$13.34B(+1.4%)
Sep 2007
-
$3.18B(-4.1%)
$13.16B(-5.1%)
Jun 2007
-
$3.32B(+4.9%)
$13.86B(+2.9%)
Mar 2007
-
$3.16B(-9.5%)
$13.47B(+3.6%)
Dec 2006
$11.97B(+8.1%)
$3.50B(-10.0%)
$13.01B(+36.8%)
Sep 2006
-
$3.88B(+32.6%)
$9.51B(+69.0%)
Jun 2006
-
$2.93B(+8.5%)
$5.63B(+108.5%)
Mar 2006
-
$2.70B(>+9900.0%)
$2.70B(>+9900.0%)
Dec 2005
$11.08B(+7.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
$10.35B(+11.9%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2004
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2004
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2003
$9.26B(+14.6%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2003
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2003
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2002
$8.08B(+7.5%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2002
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2001
$7.51B(-2.5%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2001
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2001
-
$0.00(0.0%)
$1.65B(0.0%)
Dec 2000
$7.71B(+4.9%)
$0.00(-100.0%)
$1.65B(0.0%)
Jun 2000
-
$1.65B
$1.65B
Dec 1999
$7.35B(+0.8%)
-
-
Dec 1998
$7.29B(-2.6%)
-
-
Dec 1997
$7.48B(-21.9%)
-
-
Dec 1996
$9.58B(-1.4%)
-
-
Dec 1995
$9.72B(+4.7%)
-
-
Dec 1994
$9.29B(+2.9%)
-
-
Dec 1993
$9.02B
-
-

FAQ

  • What is Novartis AG annual SGA?
  • What is the all time high annual SGA for Novartis AG?
  • What is Novartis AG annual SGA year-on-year change?
  • What is Novartis AG quarterly SGA?
  • What is the all time high quarterly SGA for Novartis AG?
  • What is Novartis AG quarterly SGA year-on-year change?
  • What is Novartis AG TTM SGA?
  • What is the all time high TTM SGA for Novartis AG?
  • What is Novartis AG TTM SGA year-on-year change?

What is Novartis AG annual SGA?

The current annual SGA of NVS is $0.00

What is the all time high annual SGA for Novartis AG?

Novartis AG all-time high annual SGA is $17.86B

What is Novartis AG annual SGA year-on-year change?

Over the past year, NVS annual SGA has changed by -$12.52B (-100.00%)

What is Novartis AG quarterly SGA?

The current quarterly SGA of NVS is $3.50B

What is the all time high quarterly SGA for Novartis AG?

Novartis AG all-time high quarterly SGA is $5.08B

What is Novartis AG quarterly SGA year-on-year change?

Over the past year, NVS quarterly SGA has changed by +$406.27M (+13.14%)

What is Novartis AG TTM SGA?

The current TTM SGA of NVS is $174.22B

What is the all time high TTM SGA for Novartis AG?

Novartis AG all-time high TTM SGA is $217.64B

What is Novartis AG TTM SGA year-on-year change?

Over the past year, NVS TTM SGA has changed by +$161.75B (+1297.55%)
On this page